• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Review of quinolones in the treatment of infections of the skin and skin structure.

作者信息

Gentry L O

机构信息

Infectious Diseases Section, St. Luke's Episcopal Hospital, Houston, Texas.

出版信息

J Antimicrob Chemother. 1991 Dec;28 Suppl C:97-110. doi: 10.1093/jac/28.suppl_c.97.

DOI:10.1093/jac/28.suppl_c.97
PMID:1787128
Abstract

The oral fluoroquinolones ciprofloxacin, ofloxacin and temafloxacin are active against staphylococci, Enterobacteriaceae and Pseudomonas aeruginosa. Ciprofloxacin has been extensively studied, and is as effective as parenteral third-generation cephalosporins in many difficult infections of the skin and skin structure. Ofloxacin has been less extensively studied, yet is probably more effective than ciprofloxacin against Staphylococcus aureus, while less effective against P. aeruginosa. Temafloxacin is an oral quinolone, and appears to be a promising agent for skin and soft tissue infections due to its extended spectrum of activity, including anaerobic pathogens. Oral fluoroquinolone monotherapy, when combined with surgical debridement and local management, may be effective in many difficult infections of the skin and skin structure previously treated with parenteral antibiotics.

摘要

相似文献

1
Review of quinolones in the treatment of infections of the skin and skin structure.
J Antimicrob Chemother. 1991 Dec;28 Suppl C:97-110. doi: 10.1093/jac/28.suppl_c.97.
2
Therapy with newer oral beta-lactam and quinolone agents for infections of the skin and skin structures: a review.
Clin Infect Dis. 1992 Jan;14(1):285-97. doi: 10.1093/clinids/14.1.285.
3
Systemic antimicrobial therapy in skin and skin structure infections: comparison of temafloxacin and ciprofloxacin.皮肤及皮肤结构感染的全身抗菌治疗:替马沙星与环丙沙星的比较
Am J Med. 1991 Dec 30;91(6A):115S-119S. doi: 10.1016/0002-9343(91)90322-o.
4
Systemic management of cutaneous bacterial infections.皮肤细菌感染的系统管理
Am J Med. 1991 Dec 30;91(6A):106S-110S. doi: 10.1016/0002-9343(91)90320-w.
5
Fluoroquinolone antibiotics: properties of the class and individual agents.氟喹诺酮类抗生素:该类及各药物的特性
Clin Ther. 1992 May-Jun;14(3):348-75; discussion 347.
6
Temafloxacin: an overview.
Am J Med. 1991 Dec 30;91(6A):166S-172S. doi: 10.1016/0002-9343(91)90332-r.
7
Rufloxacin (MF-934): in vitro and in vivo antibacterial activity.芦氟沙星(MF - 934):体内外抗菌活性
Drugs Exp Clin Res. 1989;15(1):11-5.
8
Sparfloxacin versus ciprofloxacin for the treatment of community-acquired, complicated skin and skin-structure infections.司帕沙星与环丙沙星治疗社区获得性复杂性皮肤及皮肤结构感染的比较
Clin Ther. 1999 Apr;21(4):675-90. doi: 10.1016/S0149-2918(00)88319-8.
9
The in-vitro activity of temafloxacin compared with other antimicrobial agents.替马沙星与其他抗菌药物相比的体外活性。
J Antimicrob Chemother. 1991 Jun;27(6):769-79. doi: 10.1093/jac/27.6.769.
10
Temafloxacin: in vitro comparison with five other antibacterial agents.替马沙星:与其他五种抗菌剂的体外比较
Chemotherapy. 1991;37(2):98-105. doi: 10.1159/000238840.

引用本文的文献

1
Unusual and Unconsidered Mechanisms of Bacterial Resilience and Resistance to Quinolones.细菌对喹诺酮类药物产生耐受性和耐药性的异常及未被重视的机制
Life (Basel). 2024 Mar 14;14(3):383. doi: 10.3390/life14030383.
2
Intravenous or sequential ciprofloxacin therapy in hospitalised patients with a broad spectrum of infections: a post-marketing surveillance study.住院患者使用环丙沙星进行静脉或序贯治疗以应对多种感染:一项上市后监测研究
Clin Drug Investig. 2006;26(11):645-54. doi: 10.2165/00044011-200626110-00004.
3
Newer treatment options for skin and soft tissue infections.
皮肤和软组织感染的新型治疗选择。
Drugs. 2004;64(15):1621-42. doi: 10.2165/00003495-200464150-00002.
4
A practical guide to the treatment of complicated skin and soft tissue infections.复杂皮肤及软组织感染治疗实用指南
Drugs. 2003;63(14):1459-80. doi: 10.2165/00003495-200363140-00003.
5
The Role of Fluoroquinolones in the Treatment of Skin and Soft Tissue Infection.氟喹诺酮类药物在皮肤及软组织感染治疗中的作用
Curr Infect Dis Rep. 2002 Oct;4(5):426-432. doi: 10.1007/s11908-002-0010-6.
6
Clinafloxacin versus piperacillin-tazobactam in treatment of patients with severe skin and soft tissue infections.克林沙星与哌拉西林-他唑巴坦治疗重症皮肤及软组织感染患者的疗效比较
Antimicrob Agents Chemother. 2001 Feb;45(2):525-31. doi: 10.1128/AAC.45.2.525-531.2001.
7
The appropriate use of quinolones.喹诺酮类药物的合理使用。
Drugs. 1996;52 Suppl 2:34-6. doi: 10.2165/00003495-199600522-00007.
8
Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.环丙沙星。对其药理学、治疗效果及耐受性的最新综述。
Drugs. 1996 Jun;51(6):1019-74. doi: 10.2165/00003495-199651060-00010.
9
Activity of quinolones against gram-positive cocci: clinical features.喹诺酮类药物对革兰氏阳性球菌的活性:临床特征
Drugs. 1995;49 Suppl 2:58-66. doi: 10.2165/00003495-199500492-00010.
10
Efficacies of ABT-719 and related 2-pyridones, members of a new class of antibacterial agents, against experimental bacterial infections.新型抗菌剂ABT-719及相关2-吡啶酮对实验性细菌感染的疗效。
Antimicrob Agents Chemother. 1995 Apr;39(4):971-5. doi: 10.1128/AAC.39.4.971.